Advertisement

Advertisement

IPSC Stock Latest News

Century Therapeutics Adds Director, Advances Cell Therapy Pipeline

Company AnnouncementsCentury Therapeutics Adds Director, Advances Cell Therapy Pipeline

Century Therapeutics reports Q2 EPS (17c), consensus (12c)

PremiumThe Fly

Century Therapeutics reports Q2 EPS (17c), consensus (12c)

27d ago

Phil Nadeau Initiates Buy on Century Therapeutics, Citing Promising T1D Program, Advancing Pipeline, and Strong Cash Runway

PremiumRatings

Phil Nadeau Initiates Buy on Century Therapeutics, Citing Promising T1D Program, Advancing Pipeline, and Strong Cash Runway

1M ago

Century Therapeutics Reports Q2 Results, Pipeline Advancements

PremiumCompany Announcements

Century Therapeutics Reports Q2 Results, Pipeline Advancements

1M ago

Century Therapeutics Shareholders Approve Directors and Share Increase

PremiumCompany Announcements

Century Therapeutics Shareholders Approve Directors and Share Increase

3M ago

Century Therapeutics presents new preclinical data for CNTY-813

PremiumThe FlyCentury Therapeutics presents new preclinical data for CNTY-813

3M ago

Century Therapeutics Advances CNTY-813 Diabetes Cell Therapy

Company Announcements

Century Therapeutics Advances CNTY-813 Diabetes Cell Therapy

3M ago

Century Therapeutics initiated with an Outperform at Mizuho

The Fly

Century Therapeutics initiated with an Outperform at Mizuho

4M ago

Century Therapeutics reports Q1 EPS (11c), consensus (17c)

PremiumThe Fly

Century Therapeutics reports Q1 EPS (11c), consensus (17c)

4M ago

Century Therapeutics price target raised to $5 from $2 at H.C. Wainwright

PremiumThe Fly

Century Therapeutics price target raised to $5 from $2 at H.C. Wainwright

5M ago

Century Therapeutics Updates ATM Program to Enhance Liquidity

PremiumCompany Announcements

Century Therapeutics Updates ATM Program to Enhance Liquidity

6M ago

Century Therapeutics Reports 2025 Results and Pipeline Progress

PremiumCompany Announcements

Century Therapeutics Reports 2025 Results and Pipeline Progress

6M ago

Century Therapeutics reports FY25 EPS (14c), consensus (17c)

PremiumThe FlyCentury Therapeutics reports FY25 EPS (14c), consensus (17c)

6M ago

IPSC Upcoming Earnings Report: What to Expect?

Pre-Earnings

IPSC Upcoming Earnings Report: What to Expect?

6M ago

Century Therapeutics initiated with a Buy at TD Cowen

The Fly

Century Therapeutics initiated with a Buy at TD Cowen

7M ago

Century Therapeutics files to sell 176.09M shares of common stock for holders

PremiumThe Fly

Century Therapeutics files to sell 176.09M shares of common stock for holders

7M ago

Century Therapeutics Regains Nasdaq Compliance, Halts Reverse Split

PremiumCompany Announcements

Century Therapeutics Regains Nasdaq Compliance, Halts Reverse Split

8M ago

Century Therapeutics price target raised to $4 from $2 at Piper Sandler

PremiumThe Fly

Century Therapeutics price target raised to $4 from $2 at Piper Sandler

8M ago

Century Therapeutics Highlights Progress in Immune-Evasive Cell Therapies

PremiumCompany Announcements

Century Therapeutics Highlights Progress in Immune-Evasive Cell Therapies

8M ago

Century Therapeutics price target lowered to $6.60 from $8 at Clear Street

PremiumThe FlyCentury Therapeutics price target lowered to $6.60 from $8 at Clear Street

8M ago

Century Therapeutics Announces Oversubscribed $135 Million Financing

Company Announcements

Century Therapeutics Announces Oversubscribed $135 Million Financing

8M ago

Century Therapeutics prices 117.4M shares at $1.15 in private placement

The Fly

Century Therapeutics prices 117.4M shares at $1.15 in private placement

8M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >